Zhou H - Search Results

1

Effectiveness and safety of upadacitinib in acute severe ulcerative colitis patients from single Chinese IBD Center: a monocentric study.

Zhang J, Li R, Chen L, Wang F, Zhou H, Liu X, Fan Z, Shi Y, Wu T, Wu K, Liang J. Zhang J, et al. Among authors: zhou h. Clin Exp Med. 2024 Sep 30;24(1):233. doi: 10.1007/s10238-024-01468-z. Clin Exp Med. 2024. PMID: 39348049 Free PMC article.

2

Unusual cause of abdominal pain and papule.

Zhou H, Chen F, Wang J, Liu X, Liang J. Zhou H, et al. Gut. 2022 Aug;71(8):1550-1612. doi: 10.1136/gutjnl-2021-324270. Epub 2021 Mar 8. Gut. 2022. PMID: 33685967 Free PMC article. No abstract available.

3

Patients and physicians' attitudes change on fecal microbiota transplantation for inflammatory bowel disease over the past 3 years.

Zhang Y, Xue X, Su S, Zhou H, Jin Y, Shi Y, Lin J, Wang J, Li X, Yang G, Philpott JR, Liang J. Zhang Y, et al. Among authors: zhou h. Ann Transl Med. 2021 Nov;9(21):1619. doi: 10.21037/atm-21-3683. Ann Transl Med. 2021. PMID: 34926663 Free PMC article.

4

Idiopathic mesenteric phlebosclerosis occurring after long-term medication with licorice: A case report.

Jin YR, Zhou H, Liu ZZ, Li XF, Liang J. Jin YR, et al. Among authors: zhou h. J Dig Dis. 2022 Mar;23(3):183-185. doi: 10.1111/1751-2980.13087. Epub 2022 Mar 8. J Dig Dis. 2022. PMID: 35156308 No abstract available.

5

Sec62 promotes gastric cancer metastasis through mediating UPR-induced autophagy activation.

Su S, Shi YT, Chu Y, Jiang MZ, Wu N, Xu B, Zhou H, Lin JC, Jin YR, Li XF, Liang J. Su S, et al. Among authors: zhou h. Cell Mol Life Sci. 2022 Feb 15;79(2):133. doi: 10.1007/s00018-022-04143-2. Cell Mol Life Sci. 2022. PMID: 35165763 Free PMC article.

6

Long noncoding RNA LINC00239 inhibits ferroptosis in colorectal cancer by binding to Keap1 to stabilize Nrf2.

Han Y, Gao X, Wu N, Jin Y, Zhou H, Wang W, Liu H, Chu Y, Cao J, Jiang M, Yang S, Shi Y, Xie X, Chen F, Han Y, Qin W, Xu B, Liang J. Han Y, et al. Among authors: zhou h. Cell Death Dis. 2022 Aug 29;13(8):742. doi: 10.1038/s41419-022-05192-y. Cell Death Dis. 2022. PMID: 36038548 Free PMC article.

7

Systematic Review and Meta-Analysis of Observational Studies on the Effectiveness and Safety of Ustekinumab among Patients with Inflammatory Bowel Disease in Eastern and Western Countries.

Zhou H, Wang F, Wan J, Su S, Shi Y, Li X, Wu T, Liang J. Zhou H, et al. J Clin Med. 2023 Feb 27;12(5):1894. doi: 10.3390/jcm12051894. J Clin Med. 2023. PMID: 36902681 Free PMC article. Review.

8

Successful treatment of a refractory intestinal Behcet's disease with an oncology history by Vedolizumab: a case report and literature review.

Li R, Li X, Zhou H, Shi Y, Wang F, Wu T, Liang J. Li R, et al. Among authors: zhou h. Front Immunol. 2023 May 23;14:1205046. doi: 10.3389/fimmu.2023.1205046. eCollection 2023. Front Immunol. 2023. PMID: 37287984 Free PMC article. Review.

9

Efficacy and safety of adalimumab biosimilar (HS016) in inflammatory bowel disease from the real-world study.

Wang F, Li X, Shi Y, Zhou H, Yang G, Li R, Wu T, Liang J. Wang F, et al. Among authors: zhou h. Front Pharmacol. 2023 Oct 16;14:1259183. doi: 10.3389/fphar.2023.1259183. eCollection 2023. Front Pharmacol. 2023. PMID: 37908975 Free PMC article.

10

The change of healthcare service in Chinese patients with inflammatory bowel disease during the pandemic: a national multicenter cross-sectional study.

Li X, Wang F, Jia Y, Zhou H, Shi Y, Tian F, Chen Y, Liang J. Li X, et al. Among authors: zhou h. Sci Rep. 2023 Nov 16;13(1):20084. doi: 10.1038/s41598-023-46892-5. Sci Rep. 2023. PMID: 37973924 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35,784 results

Search Page

Filters